Upgrade to SI Premium - Free Trial

Danaher (DHR) PT Lowered to $220 at Stifel on Bioprocess Underperformance

July 22, 2026 7:14 AM
Stifel analyst Daniel Arias lowered the price target on Danaher (NYSE: DHR) to $220.00 (from $260.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change